A detailed history of Stonebridge Capital Advisors LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Stonebridge Capital Advisors LLC holds 17,500 shares of DMAC stock, worth $78,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,500
Previous 20,000 12.5%
Holding current value
$78,400
Previous $59,000 23.73%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.8 - $4.49 $7,000 - $11,225
-2,500 Reduced 12.5%
17,500 $73,000
Q3 2023

Nov 15, 2023

BUY
$2.56 - $4.4 $51,200 - $88,000
20,000 New
20,000 $51,000

Others Institutions Holding DMAC

About DiaMedica Therapeutics Inc.


  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $118M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Stonebridge Capital Advisors LLC Portfolio

Follow Stonebridge Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.